07 Jan 2001

Rhinomer® 1 (Rhinomer® 1 (Soft)/-2 (Medium)/-3 (Intensiv) Lösung) - Deutschland

Updated: 07 Jan 2001

Rhinomer® 1 (Soft) | -2 (Medium) | -3 (Intensiv)

Rhinomer 1 (Soft): Reinigung u. sanfte Spülung d. Nasenhöhle, z. B. als begleitende Maßnahme b. Schnupfen. Anw. auch für Sgl. u. Kleinkdr. Zum Anfeuchten d. Nasenschleimhaut (z. B. b. geringer Luftfeuchtigkeit in geheizten od. klimatisierten Räumen), Reinigung d. Nasenhöhle b. vermehrter Luftbelastung (z. B. Staub etc.). Für jede Altersgruppe. Rhinomer 2 (Medium): Reinigung d. Nasenhöhle, z. B. zum Lösen v. Krusten, Anw. vor u. nach Nasenoperationen, b. vermehrter Luftbelastung (z. B. Staub etc.), als begleitende Maßnahme b. Schnupfen. Für Kdr. ab 2 J. u. Erw. Rhinomer 3 (Intensiv): Intensive Reinigung d. Nasenhöhle, z. B. zum Lösen von Krusten, Anw. vor u. nach Nasenoperationen, begleitende Maßnahme bei Schnupfen. Für Kdr. 6 J. u. Erw.

Rhinomer® 1 Description, Presentation and Dosage

Rhinomer® 1 Description

Rhinomer® 1 Drug Class Description

Andere Stoffe

Rhinomer® 1 Drug Description

1 ml enth.: steriles, isotonisiertes Meerwasser entspr. einer 0,9%igen NaCl-Lsg.

Rhinomer® 1 Generic Name

Rhinomer® 1 (Soft)/-2 (Medium)/-3 (Intensiv) Lösung

Rhinomer® 1 Presentation

Rhinomer® 1 Presentation

Rhinomer® 1 (Soft)/-2 (Medium)/-3 (Intensiv)

Rhinomer® 1 Manufacturer

Novartis Consumer Health

Related Learning Zones

LAL-D Knowledge Centre

LAL-D Knowledge Centre

The Lysosomal Acid Lipase (LAL) Deficiency Knowledge Centre contains a range of accurate, informative clinical content for healthcare professionals. The disease awareness section presents epidemiology, pathophysiology and diagnosis information, among others. The treatment section details the drug characteristics, safety and efficacy of sebelipase alfa – the first and only licenced treatment for LAL deficiency. The resources section contains further clinical content including a video channel presenting expert opinions on diagnostic approach and current prognosis.

Developed by EPG Health Media (Europe) Ltd for epgonline.org, in collaboration and with content provided by Alexion Pharma GmbH

Prostate Cancer Learning Hub

Prostate Cancer Learning Hub

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer. The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer.

Rhinomer® 1 Dosage

Rhinomer® 1 Adult Dosage

keine.

Rhinomer® 1 Precautions, Reactions and Contraindications

Rhinomer® 1 Special Precautions

Rhinomer® 1 Special Precautions

Rhinomer 2: Kdr.

Related Drugs - Ear, Nose and Throat

Back to top